Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 6 | 6 |
| List of Tables | 9 | 2 |
| List of Figures | 11 | 1 |
| Introduction | 12 | 1 |
| Global Neurostimulation Devices Market - An Overview | 13 | 1 |
| Spinal Cord Stimulator | 13 | 1 |
| Deep Brain Stimulator | 13 | 1 |
| Vagus Nerve Stimulator | 13 | 1 |
| Sacral Nerve Stimulator | 13 | 1 |
| Cortical Stimulator | 13 | 1 |
| Global Neurostimulation Devices Market - Market Characterization | 14 | 10 |
| Global Neurostimulation Devices Market, Revenue ($m), 2004-2011 | 14 | 1 |
| Global Neurostimulation Devices Market, Revenue ($m), 2011-2018 | 15 | 2 |
| Global Neurostimulation Devices Market, Key Company Share (%), 2010 | 17 | 1 |
| Global Neurostimulation Devices Market: Key Trends | 18 | 1 |
| Application of Neurostimulation Technology for Treatment with New Therapies | 18 | 1 |
| Increasing Investments by Private Equity and Venture Capital Firms in Start-up Companies | 19 | 1 |
| Global Neurostimulation Devices Market: Market Dynamics | 20 | 1 |
| Market Drivers | 20 | 1 |
| Neurostimulation Technology Innovations and Advancements will Drive Market Growth | 20 | 1 |
| Recent Product Approvals will Increase Demand and Drive Market Growth | 20 | 1 |
| Increase in the Elderly Population will Accelerate Market Growth | 21 | 1 |
| Increase in the Prevalence of Neurological Diseases and Disorders to Drive Market Growth | 22 | 1 |
| Market Restraints | 22 | 1 |
| Product Recalls will Affect Physician and Patient Perceptions, Decrease Adoption Rates and Hinder Market Growth | 22 | 1 |
| High Cost, Limited Reimbursements and Low Insurance Coverage Restrains Market Growth | 23 | 1 |
| Global Neurostimulation Devices Market: Segment Analysis and Forecasts | 24 | 16 |
| Spinal Cord Stimulators Market, Global, Revenue ($m), 2004-2011 | 24 | 1 |
| Spinal Cord Stimulators Market, Global, Revenue ($m), 2011-2018 | 25 | 1 |
| Spinal Cord Stimulators: Market Dynamics | 26 | 1 |
| Market Drivers | 26 | 1 |
| Increase in Adoption Rates Due to Better Efficacy and Safety of Devices to Drive Market Growth | 26 | 1 |
| The Cost Effectiveness of Spinal Cord Stimulation in the Treatment of Pain Drives Market Growth | 26 | 1 |
| Increase in Awareness of Spinal Cord Stimulation Therapy to Drive Market Growth | 26 | 1 |
| Market Restraints | 27 | 1 |
| Surgical Complications Associated with Device Implantation Affects Market Growth | 27 | 1 |
| Lack of Skilled Surgeons in India and China Restrains Market Growth | 27 | 1 |
| Deep Brain Stimulators Market, Global, Revenue ($m), 2004-2011 | 27 | 2 |
| Deep Brain Stimulators Market, Global, Revenue ($m), 2011-2018 | 29 | 1 |
| Deep Brain Stimulators: Market Dynamics | 30 | 1 |
| Market Drivers | 30 | 1 |
| Technological Advancements will Increase Acceptance Rates and Drive Market Growth | 30 | 1 |
| Product Approvals in the Near Future will Boost Market Growth | 30 | 1 |
| Adoption of New Indications Currently in Clinical Trials will Drive Market Growth | 30 | 1 |
| Market Restraints | 30 | 1 |
| Surgical Complications Associated with Device Implantation Restrain Market Growth | 30 | 1 |
| Vagus Nerve Stimulators Market, Global, Revenue ($m), 2004-2011 | 31 | 1 |
| Vagus Nerve Stimulators Market, Global, Revenue ($m), 2011-2018 | 32 | 1 |
| Vagus Nerve Stimulators: Market Dynamics | 33 | 1 |
| Market Drivers | 33 | 1 |
| Increase in Prevalence of Epilepsy to Drive Market Growth | 33 | 1 |
| Relatively Safe Implantation Procedure and High Efficacy Rates Increase Adoption Rates and Market Growth | 33 | 1 |
| Application of Vagus Nerve Stimulation Therapy in New Indications will Drive Market Growth | 33 | 1 |
| Market Restraints | 33 | 1 |
| Low Adoption Rates Due to Lack of Awareness Hinders Market Growth | 33 | 1 |
| Sacral Nerve Stimulators Market, Global, Revenue ($m), 2004-2011 | 34 | 1 |
| Sacral Nerve Stimulators Market, Global, Revenue ($m), 2011-2018 | 35 | 1 |
| Sacral Nerve Stimulators: Market Dynamics | 36 | 1 |
| Market Drivers | 36 | 1 |
| Increase in Incidence of Urinary and Bowel Disorders to Drive Market Growth | 36 | 1 |
| Market Restraints | 36 | 1 |
| Technology Limitations Hinder Market Growth | 36 | 1 |
| Cortical Stimulators Market, Global, Revenue ($m), 2004-2011 | 37 | 1 |
| Cortical Stimulators Market, Global, Revenue ($m), 2011-2018 | 38 | 1 |
| Cortical Stimulators: Market Dynamics | 39 | 1 |
| Market Drivers | 39 | 1 |
| Increasing Application of Cortical Stimulators in Brain Mapping and Epilepsy Surgery will Drive Market Growth | 39 | 1 |
| Market Restraints | 39 | 1 |
| Product Recalls Drastically Hinder Market Growth | 39 | 1 |
| Global Neurostimulation Devices Market - Country Analysis and Forecasts | 40 | 26 |
| Neurostimulation Devices Market: Cross Country Analysis | 40 | 1 |
| Historic and Forecast Revenue, By Country | 41 | 1 |
| Neurostimulation Devices Market, the US, Revenue ($m), 2004-2011 | 41 | 2 |
| Neurostimulation Devices Market, the US, Revenue ($m), 2011-2018 | 43 | 1 |
| Neurostimulation Devices Market, Canada, Revenue ($m), 2004-2011 | 44 | 1 |
| Neurostimulation Devices Market, Canada, Revenue ($m), 2011-2018 | 45 | 1 |
| Neurostimulation Devices Market, the UK, Revenue ($m), 2004-2011 | 46 | 1 |
| Neurostimulation Devices Market, the UK, Revenue ($m), 2011-2018 | 47 | 1 |
| Neurostimulation Devices Market, Germany, Revenue ($m), 2004-2011 | 48 | 1 |
| Neurostimulation Devices Market, Germany, Revenue ($m), 2011-2018 | 49 | 1 |
| Neurostimulation Devices Market, France, Revenue ($m), 2004-2011 | 50 | 1 |
| Neurostimulation Devices Market, France, Revenue ($m), 2011-2018 | 51 | 1 |
| Neurostimulation Devices Market, Italy, Revenue ($m), 2004-2011 | 52 | 1 |
| Neurostimulation Devices Market, Italy, Revenue ($m), 2011-2018 | 53 | 1 |
| Neurostimulation Devices Market, Spain, Revenue ($m), 2004-2011 | 54 | 1 |
| Neurostimulation Devices Market, Spain, Revenue ($m), 2011-2018 | 55 | 1 |
| Neurostimulation Devices Market, Japan, Revenue ($m), 2004-2011 | 56 | 1 |
| Neurostimulation Devices Market, Japan, Revenue ($m), 2011-2018 | 57 | 1 |
| Neurostimulation Devices Market, China, Revenue ($m), 2004-2011 | 58 | 1 |
| Neurostimulation Devices Market, China, Revenue ($m), 2011-2018 | 59 | 1 |
| Neurostimulation Devices Market, India, Revenue ($m), 2004-2011 | 60 | 1 |
| Neurostimulation Devices Market, India, Revenue ($m), 2011-2018 | 61 | 1 |
| Neurostimulation Devices Market, Australia, Revenue ($m), 2004-2011 | 62 | 1 |
| Neurostimulation Devices Market, Australia, Revenue ($m), 2011-2018 | 63 | 1 |
| Neurostimulation Devices Market, Brazil, Revenue ($m), 2004-2011 | 64 | 1 |
| Neurostimulation Devices Market, Brazil, Revenue ($m), 2011-2018 | 65 | 1 |
| Global Neurostimulation Devices Market - Competitive Assessment | 66 | 5 |
| Medtronic, Inc. | 66 | 1 |
| Business Overview | 66 | 1 |
| Key Marketed Products | 67 | 1 |
| St. Jude Medical, Inc. | 68 | 1 |
| Business Overview | 68 | 1 |
| Key Marketed Products | 68 | 1 |
| Boston Scientific Corporation | 69 | 1 |
| Business Overview | 69 | 1 |
| Key Marketed Products | 69 | 1 |
| Cyberonics, Inc. | 70 | 1 |
| Business Overview | 70 | 1 |
| Key Marketed Products | 70 | 1 |
| Global Neurostimulation Devices Market: Pipeline Analysis | 71 | 20 |
| Introduction | 71 | 1 |
| Neurostimulation Devices: Pipeline Assessment, by Segment | 71 | 1 |
| Neurostimulation Devices: Pipeline Assessment, by Stage of Development | 72 | 1 |
| Neurostimulation Devices: Pipeline Assessment | 73 | 1 |
| Spinal Cord Stimulators: Product Pipeline | 73 | 1 |
| Spinal Cord Stimulators: List of Pipeline Products | 73 | 1 |
| Spinal Cord Stimulators: Profiles of Key Pipeline Products | 74 | 1 |
| PrimeADVANCED - Heart Failure (Defeat-HF) | 74 | 1 |
| Genesis Neurostimulation System | 74 | 1 |
| SAINT System | 75 | 1 |
| Next Generation SCS System | 75 | 1 |
| Precision Plus SCS System | 76 | 1 |
| Deep Brain Stimulators: Product Pipeline | 77 | 1 |
| Deep Brain Stimulators: List of Pipeline Products | 77 | 1 |
| Deep Brain Stimulators: Profiles of Key Pipeline Products | 78 | 1 |
| Activa PC | 78 | 1 |
| CR-Capable Implant | 78 | 1 |
| Enspire DBS Therapy System | 78 | 1 |
| ESStim 101 | 79 | 1 |
| Libra Deep Brain Stimulation System | 79 | 1 |
| Vercise DBS System | 80 | 1 |
| directSTIM | 80 | 1 |
| spiderSTIM | 80 | 1 |
| Synapse | 81 | 1 |
| Vagus Nerve Stimulators: Product Pipeline | 82 | 1 |
| Vagus Nerve Stimulators: List of Pipeline Products | 82 | 1 |
| Vagus Nerve Stimulators: Profiles of Key Pipeline Products | 83 | 1 |
| Aspire NP | 83 | 1 |
| FitNes System | 83 | 1 |
| SAINT System | 84 | 1 |
| NEMOS (t-VNS) | 84 | 1 |
| Pulse Generator | 85 | 1 |
| Sacral Nerve Stimulators: Product Pipeline | 85 | 1 |
| Sacral Nerve Stimulators: List of Pipeline Products | 85 | 1 |
| Sacral Nerve Stimulators: Profiles of Key Pipeline Products | 85 | 1 |
| Sacral Nerve Stimulation Device | 85 | 1 |
| SAINT System | 86 | 1 |
| Verv System | 86 | 1 |
| Cortical Stimulators: Product Pipeline | 87 | 1 |
| Cortical Stimulators: List of Pipeline Products | 87 | 1 |
| Cortical Stimulators: Profiles of Key Pipeline Products | 87 | 1 |
| cortiSTIM | 87 | 1 |
| Other Neurostimulation Devices - Product Pipeline | 88 | 1 |
| Other Neurostimulation Devices - List of Pipeline Products | 88 | 3 |
| Global Neurostimulation Devices Market - Consolidation Landscape | 91 | 7 |
| Neurostimulation Devices Market: Deals by Number and Deal Value, 2007-2012 | 91 | 1 |
| Key Mergers and Acquisitions 2012 (Q1, Q2) | 92 | 1 |
| Greatbatch Acquires NeuroNexus Technologies | 92 | 1 |
| Deal Rationale | 92 | 1 |
| Key Mergers and Acquisitions: 2007-2011 | 93 | 1 |
| Boston Scientific s Acquisition of Intelect Medical | 93 | 1 |
| Deal Rationale | 93 | 1 |
| Otto Bock HealthCare s Acquisition of Neurostream Technologies from Victhom Human Bionics | 93 | 1 |
| Deal Rationale | 93 | 1 |
| St. Jude Medical s Acquisition of Northstar Neuroscience | 94 | 1 |
| Deal Rationale | 94 | 1 |
| Medtronic s Acquisition of NDI s Medstim System | 94 | 1 |
| Deal Rationale | 94 | 1 |
| Greatbatch s Acquisition of Quan Emerteq | 94 | 1 |
| Deal Rationale | 94 | 1 |
| Greatbatch s Acquisition of Enpath Medical | 94 | 1 |
| Deal Rationale | 94 | 1 |
| Key Partnership Deals: 2007-2010 | 95 | 1 |
| EndoStim s Agreement with Arizona State University | 95 | 1 |
| Ardiem Medical s Licensing Agreement with Case Western Reserve University | 95 | 1 |
| Neurowave Medical Technologies Licensing Agreement with Alaven Pharma | 96 | 1 |
| Cyberonics Licensing Agreement with NeuroVista | 96 | 1 |
| Victhom Human Bionics Joint Venture Agreement with Otto Bock HealthCare | 96 | 1 |
| Cyberonics Agreement with Nihon Kohden | 96 | 1 |
| Cyberonics Licensing Agreement with Massachusetts Institute of Technology | 96 | 1 |
| NeuroNexus Technologies Research Agreement with Philips Research | 96 | 1 |
| Intelect Medical s Agreement with Boston Scientific | 97 | 1 |
| Cyberonics Licensing Agreement with Southern Illinois University | 97 | 1 |
| Cyberonics Licensing Agreement with Ethicon Endo-Surgery | 97 | 1 |
| Innovative Neurotronics Agreement with Teijin Pharma | 97 | 1 |
| Appendix | 98 | 6 |
| Definitions | 98 | 1 |
| Neurostimulation Devices | 98 | 1 |
| Cortical Stimulators | 98 | 1 |
| Deep Brain Stimulators | 98 | 1 |
| Sacral Nerve Stimulators | 98 | 1 |
| Spinal Cord Stimulators | 98 | 1 |
| Vagus Nerve Stimulators | 98 | 1 |
| Prevalence or Diseased Population | 98 | 1 |
| Sources | 98 | 1 |
| Acronyms | 99 | 2 |
| Research Methodology | 101 | 2 |
| Secondary Research | 101 | 1 |
| Primary Research | 101 | 1 |
| Models | 102 | 1 |
| Forecasts | 102 | 1 |
| Expert Panels | 102 | 1 |
| Contact Us | 102 | 1 |
| Disclaimer | 103 | 1 |
